Purdue Pharma, the maker of OxyContin, has been granted an 18-day extension to negotiate a comprehensive settlement for its opioid litigation. This comes after the Supreme Court rejected a previous plan that would have shielded the Sackler family from lawsuits. The extension allows Purdue to modify its approach and potentially salvage parts of the original settlement.